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Association between smoking 
cessation and obstructive 
spirometry pattern among Korean 
adults aged 40–79 years
Yeo Jun Yoon1,5, Myung Soo Lee1,5, Kyu Won Jang1,5, Jae Bum Ahn2, Kyungduk Hurh3,4* & 
Eun‑Cheol Park3,4*
Smoking cessation aids in restoring lung function. However, whether long‑term cessation can fully 
restore lung function has not been studied thoroughly, especially in Asian countries. This study aimed 
to evaluate the association between smoking cessation status and obstructive spirometry pattern 
among Koreans aged 40–79 years. In total, 6298 men and 8088 women aged 40–79 years from the 
Korea National Health and Nutrition Examination Survey (2015–2019) were analyzed for smoking 
cessation status, including the duration after quitting. Current‑smokers showed a higher likelihood 
of having an obstructive spirometry pattern than never‑smokers among both men (odds ratio [OR]: 
3.15, 95% confidence interval [CI]: 2.32–4.29) and women (OR: 2.60, 95% CI: 1.59–4.23). In men, the 
effect tended to decrease with longer duration after cessation, but male ex‑smokers who had quit 
smoking ≥ 20 years ago still showed a higher likelihood of having an obstructive spirometry pattern 
than male never‑smokers (OR: 1.40, 95% CI: 1.05–1.89). In female ex‑smokers, there was no significant 
association with the obstructive spirometry pattern, compared to that in female never‑smokers. This 
study emphasizes the benefits of smoking cessation, possibility of long‑lasting harm to lung function 
due to tobacco smoking, and importance of smoking prevention.
Chronic obstructive pulmonary lung disease (COPD) is a progressive life-threatening lung disease and a major 
public health problem  worldwide1. Globally, 251 million cases of COPD are reported, and it accounts for approxi-
mately 5% of all  deaths2.
The primary causative factor of COPD is tobacco smoking. Studies have revealed that 15–50% of elderly 
smokers eventually develop COPD, and 40–70% of COPD cases are attributed to tobacco  smoking3–6.
Usually, lung function reaches its maximal capacity at the age of 20–25 years and thereafter declines gradu-
ally with  aging7,8. Smoking accelerates this age-related decline in lung function and eventually results in chronic 
airway  obstruction8–10. Particularly, greater smoking volume, or adolescent-onset smoking, is known to be associ-
ated with a high risk of lung function impairment and  COPD11–13.
Smoking cessation could alleviate the accelerated decline in lung function, and prevent development and pro-
gression of  COPD12,14,15. Three to five years after smoking cessation, the age-related  FEV1 decline almost halved 
in ex-smokers compared to that in current  smokers13,16. More recent studies have explored whether long-term 
smoking cessation could completely normalize lung function, and if so, how long it will take for full restoration. 
A meta-analysis reported that the  FEV1 decline in ex-smokers did not differ from that in never-smokers17. In 
contrast, the lung function of ex-smokers did not normalize even decades after smoking cessation in a prospec-
tive cohort study conducted in the US  population18. Moreover, it remains unclear whether the lung function 
of high-risk smokers, such as heavy smokers or adolescent-onset smokers, can recover to the level observed in 
other ex-smokers after long-term cessation. The impact of smoking cessation on lung function recovery has 
been well described in Western countries, while there are only few studies, conducted using reliable measuring 
instruments, focusing on long-term cessation in the Asian population.
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Therefore, this study aimed to investigate the relationship between smoking cessation status, including the 
duration after cessation, and obstructive spirometry pattern among Korean adults aged 40–79 years, using a 
nationally representative survey. We also performed an additional analysis to investigate whether the cumulative 
smoking exposure or adolescent-onset smoking affected the association between lung function and smoking 
cessation status among male participants. Lastly, to minimize age differences across categories of smoking ces-
sation status, separate analyses were performed after dividing the study participants into 10-year age groups.
Results
Among 6298 men, 1111 (17.6%) were never-smokers; 2001 (31.8%) were current-smokers; and 1007 (16.0%), 493 
(7.8%), 528 (8.4%), 477 (7.6%), and 681 (10.8%) were ex-smokers with ≥ 20, 15–20, 10–15, 5–10, and < 5 years 
of cessation, respectively. Among 8088 women, 7379 (91.2%) were never-smokers; 344 (4.3%) were current-
smokers; and 123 (1.5%), 42 (0.5%), 74 (0.9%), 37 (0.5%), and 89 (1.1%) were ex-smokers with ≥ 20, 15–20, 10–15, 
5–10, and < 5 years of cessation, respectively. Among male and female ex-smokers with ≥ 20 years of cessation, 
787 (78.2%) and 120 (97.6%) had < 20 pack-years of smoking, respectively. On the other hand, 751 (37.5%) men 
and 281 (28.1%) women had < 20 pack-years of smoking among male and female current-smokers, respectively. 
Also, participants showed different age distributions across the smoking cessation status groups: Among men, the 
mean ages were 63.9 (SD, 9.7), 54.0 (SD, 9.6), and 57.9 (SD, 11.5) in ex-smokers with ≥ 20 of cessation, current-
smokers and never-smokers, respectively; Among women, the mean ages were 53.3 (SD, 10.7), 53.2 (SD, 9.2), and 
57.5 (SD, 10.4) in ex-smokers with ≥ 20 of cessation, current-smokers and never-smokers, respectively (Table 1).
Current-smokers showed a higher likelihood of having an obstructive spirometry pattern than never-smokers 
among both men (odds ratio [OR]: 3.15, 95% confidence interval [CI]: 2.32–4.29) and women (OR: 2.60, 95% 
CI: 1.59–4.23). Male ex-smokers were more likely to have an obstructive spirometry pattern than male never-
smokers; the risk tended to decrease with a longer duration of smoking cessation: the ORs were 1.93 (95% CI: 
1.32–2.84), 2.66 (95% CI: 1.84–3.87), 1.48 (95% CI: 1.00–2.18), 1.18 (95% CI: 0.82–1.68), and 1.40 (95% CI: 
1.05–1.89) in male ex-smokers with < 5, 5–10, 10–15, 15–20, and ≥ 20 years of cessation, respectively. Female 
Table 1.  General characteristics of the study population. SD standard deviation. a Based on the International 


















 ≥ 20 15–20 10–15 5–10  < 5  ≥ 20 15–20 10–15 5–10  < 5
N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%) N (%)
Total 6298 (100.0) 1111 (17.6) 1007 (16.0) 493 (7.8) 528 (8.4) 477 (7.6) 681 (10.8) 2001 (31.8) 8088 (100.0) 7379 (91.2) 123 (1.5) 42 (0.5) 74 (0.9) 37 (0.5) 89 (1.1) 344 (4.3)
Cumulative smoking exposure (pack-years)  < .0001
< 20 3600 (57.2) 1111 (100.0) 787 (78.2) 281 (57.0) 252 (47.7) 183 (38.4) 235 (34.5) 751 (37.5) 7997 (98.9) 7379 (100.0) 120 (97.6) 42 (100.0) 68 (91.9) 33 (89.2) 74 (83.1) 281 (81.7)
20–30 1141 (18.1) N/A 124 (12.3) 98 (19.9) 106 (20.1) 97 (20.3) 170 (25.0) 546 (27.3) 54 (0.7) N/A 1 (0.8) 0 3 (4.1) 4 (10.8) 6 (6.7) 40 (11.6)
> 30 1557 (24.7) N/A 96 (9.5) 114 (23.1) 170 (32.2) 197 (41.3) 276 (40.5) 704 (35.2) 37 (0.5) N/A 2 (1.6) 0 3 (4.1) 0 9 (10.1) 23 (6.7)
Age (years), 
mean ± SD
57.5 ± 10.7 57.9 ± 11.5 63.9 ± 9.7 59.2 ± 9.8 58.1 ± 10.0 57.2 ± 10.0 55.3 ± 10.7 54.0 ± 9.6  < .0001 57.3 ± 10.5 57.5 ± 10.4 53.3 ± 10.7 48.1 ± 8.7 51.8 ± 10.4 54.9 ± 10.8 53.9 ± 10.4 53.2 ± 9.2  < .0001
School  < .0001  < .0001
Middle school 
or below
1828 (29.0) 308 (27.7) 380 (37.7) 143 (29.0) 154 (29.2) 148 (31.0) 178 (26.1) 517 (25.8) 3306 (40.9) 3047 (41.3) 26 (21.1) 9 (21.4) 23 (31.1) 16 (43.2) 48 (53.9) 137 (39.8)
High school 2091 (33.2) 301 (27.1) 290 (28.8) 163 (33.1) 167 (31.6) 151 (31.7) 229 (33.6) 790 (39.5) 2722 (33.7) 2425 (32.9) 51 (41.5) 21 (50.0) 28 (37.8) 13 (35.1) 29 (32.6) 155 (45.1)
College or 
above
2379 (37.8) 502 (45.2) 337 (33.5) 187 (37.9) 207 (39.2) 178 (37.3) 274 (40.2) 694 (34.7) 2060 (25.5) 1907 (25.8) 46 (37.4) 12 (28.6) 23 (31.1) 8 (21.6) 12 (13.5) 52 (15.1)
Income 0.0616  < .0001
Low 978 (15.5) 170 (15.3) 182 (18.1) 71 (14.4) 75 (14.2) 71 (14.9) 105 (15.4) 304 (15.2) 1619 (20.0) 1453 (19.7) 20 (16.3) 9 (21.4) 12 (16.2) 13 (35.1) 26 (29.2) 86 (25.0)
Mid-low 1557 (24.7) 279 (25.1) 275 (27.3) 119 (24.1) 131 (24.8) 110 (23.1) 167 (24.5) 476 (23.8) 2024 (25.0) 1824 (24.7) 26 (21.1) 9 (21.4) 22 (29.7) 10 (27.0) 22 (24.7) 111 (32.3)
Mid-high 1718 (27.3) 279 (25.1) 246 (24.4) 133 (27.0) 148 (28.0) 139 (29.1) 172 (25.3) 601 (30.0) 2103 (26.0) 1892 (25.6) 41 (33.3) 14 (33.3) 24 (32.4) 12 (32.4) 24 (27.0) 96 (27.9)
High 2045 (32.5) 383 (34.5) 304 (30.2) 170 (34.5) 174 (33.0) 157 (32.9) 237 (34.8) 620 (31.0) 2342 (29.0) 2210 (29.9) 36 (29.3) 10 (23.8) 16 (21.6) 2 (5.4) 17 (19.1) 51 (14.8)
Occupationa  < .0001 0.0157
White collar 1726 (27.4) 383 (34.5) 203 (20.2) 135 (27.4) 144 (27.3) 122 (25.6) 209 (30.7) 530 (26.5) 1340 (16.6) 1239 (16.8) 23 (18.7) 6 (14.3) 16 (21.6) 3 (8.1) 15 (16.9) 38 (11.0)
Pink collar 574 (9.1) 87 (7.8) 72 (7.1) 32 (6.5) 40 (7.6) 55 (11.5) 59 (8.7) 229 (11.4) 1416 (17.5) 1259 (17.1) 25 (20.3) 10 (23.8) 15 (20.3) 6 (16.2) 18 (20.2) 83 (24.1)
Blue collar 2535 (40.3) 399 (35.9) 390 (38.7) 208 (42.2) 219 (41.5) 190 (39.8) 253 (37.2) 876 (43.8) 1588 (19.6) 1476 (20.0) 16 (13.0) 7 (16.7) 12 (16.2) 4 (10.8) 11 (12.4) 62 (18.0)
None/home-
maker
1463 (23.2) 242 (21.8) 342 (34.0) 118 (23.9) 125 (23.7) 110 (23.1) 160 (23.5) 366 (18.3) 3744 (46.3) 3405 (46.1) 59 (48.0) 19 (45.2) 31 (41.9) 24 (64.9) 45 (50.6) 161 (46.8)
Residential area 0.0716 0.0281
Capital 2601 (41.3) 437 (39.3) 419 (41.6) 217 (44.0) 215 (40.7) 193 (40.5) 289 (42.4) 831 (41.5) 3407 (42.1) 3070 (41.6) 65 (52.8) 24 (57.1) 40 (54.1) 18 (48.6) 44 (49.4) 146 (42.4)
Metropolitan 1754 (27.9) 292 (26.3) 316 (31.4) 126 (25.6) 153 (29.0) 129 (27.0) 178 (26.1) 560 (28.0) 2246 (27.8) 2071 (28.1) 32 (26.0) 10 (23.8) 17 (23.0) 7 (18.9) 25 (28.1) 84 (24.4)
Rural 1943 (30.9) 382 (34.4) 272 (27.0) 150 (30.4) 160 (30.3) 155 (32.5) 214 (31.4) 610 (30.5) 2435 (30.1) 2238 (30.3) 26 (21.1) 8 (19.0) 17 (23.0) 12 (32.4) 20 (22.5) 114 (33.1)
High-risk drinking  < .0001
No 5021 (79.7) 1006 (90.5) 888 (88.2) 407 (82.6) 417 (79.0) 377 (79.0) 527 (77.4) 1399 (69.9) 7775 (96.1) 7187 (97.4) 117 (95.1) 38 (90.5) 68 (91.9) 34 (91.9) 71 (79.8) 260 (75.6)
Yes 1277 (20.3) 105 (9.5) 119 (11.8) 86 (17.4) 111 (21.0) 100 (21.0) 154 (22.6) 602 (30.1) 313 (3.9) 192 (2.6) 6 (4.9) 4 (9.5) 6 (8.1) 3 (8.1) 18 (20.2) 84 (24.4)
Physical activity 0.0009 0.0070
Active 2849 (45.2) 545 (49.1) 468 (46.5) 237 (48.1) 247 (46.8) 219 (45.9) 309 (45.4) 824 (41.2) 3272 (40.5) 3021 (40.9) 46 (37.4) 22 (52.4) 31 (41.9) 15 (40.5) 28 (31.5) 109 (31.7)
Inactive 3449 (54.8) 566 (50.9) 539 (53.5) 256 (51.9) 281 (53.2) 258 (54.1) 372 (54.6) 1177 (58.8) 4816 (59.5) 4358 (59.1) 77 (62.6) 20 (47.6) 43 (58.1) 22 (59.5) 61 (68.5) 235 (68.3)
Height (cm), 
mean ± SD
169.2 ± 6.2 168.6 ± 6.3 167.6 ± 6.3 169.3 ± 5.8 168.9 ± 6.0 169.9 ± 5.7 170.3 ± 6.2 169.9 ± 6.3  < .0001 156.5 ± 5.9 156.3 ± 5.8 157.7 ± 5.7 159.3 ± 5.4 158.3 ± 6.7 156.2 ± 5.6 156.9 ± 5.8 158.3 ± 5.8  < .0001
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ex-smokers showed no significant association with the obstructive spirometry pattern, when compared to female 
never-smokers. Other factors associated with obstructive spirometry pattern were greater pack-years of smok-
ing (only in men), older age, residing metropolitan or rural area, physical inactivity (only in men), and higher 
height (Table 2).
Similarly,  FEV1 and  FEV1/FVC values showed an increasing tendency with longer duration of smoking ces-
sation (Supplementary Table S1).
The ORs for the obstructive spirometry pattern were 2.67 (95% CI: 1.90–3.76), 4.41 (95% CI: 3.10–6.27), and 
5.01 (95% CI: 3.73–6.74) in male current-smokers with < 20, 20–30, and ≥ 30 pack-years of smoking, respectively 
(comparison group: male never-smokers). Compared to male never-smokers, male ex-smokers with ≥ 20 years 
of cessation and < 20, 20–30, and ≥ 30 pack-years of smoking showed ORs of 1.53 (95% CI: 1.12–2.09), 1.41 
(95% CI: 0.84–2.36), and 1.66 (95% CI: 1.01–2.72) for the obstructive spirometry pattern, respectively (Fig. 1).
Compared to male never-smokers, male current-smokers who had started smoking before and after the age of 
15 years showed ORs of 4.55 (95% CI: 2.08–9.94) and 3.16 (95% CI: 2.32–4.30), respectively, for the obstructive 
spirometry pattern. Male ex-smokers who had started smoking before and after the age of 15 years and had quit 
Table 2.  Association between smoking cessation status and obstructive spirometry pattern. OR odds ratio, 
CI confidence interval. a Obstructive spirometry pattern was defined as an  FEV1/FVC < 0.7. b Based on the 
International Standard Classification Occupations codes.
Variables
Obstructive spirometry  patterna
Men Women
OR 95% CI OR 95% CI
Smoking cessation status (years of cessation)
Never-smoker 1.00 1.00
Ex-smoker (≥ 20) 1.40 (1.05 1.89) 1.08 (0.44 2.67)
Ex-smoker (15–20) 1.18 (0.82 1.68) 1.79 (0.21 15.02)
Ex-smoker (10–15) 1.48 (1.00 2.18) 1.43 (0.48 4.24)
Ex-smoker (5–10) 2.66 (1.84 3.87) 1.62 (0.44 5.98)
Ex-smoker (< 5) 1.93 (1.32 2.84) 1.32 (0.47 3.69)
Current smoker 3.15 (2.32 4.29) 2.60 (1.59 4.23)
Cumulative smoking exposure (pack-years)
 < 20 1.00 1.00
20–30 1.28 (1.02 1.62) 1.20 (0.42 3.43)
 > 30 1.47 (1.20 1.80) 1.00 (0.35 2.85)
Age (years) 1.12 (1.10 1.13) 1.09 (1.08 1.11)
Education level
Middle school or less 1.00 1.00
High school 0.84 (0.69 1.02) 1.01 (0.77 1.34)
College or over 0.82 (0.64 1.05) 0.98 (0.66 1.45)
Household income
Low 1.00 1.00
Mid-low 1.08 (0.86 1.37) 0.92 (0.70 1.21)
Mid-high 0.90 (0.70 1.15) 0.83 (0.60 1.16)
High 0.91 (0.69 1.21) 0.76 (0.53 1.09)
Occupationb
White collar 1.00 1.00
Pink collar 1.12 (0.79 1.58) 1.41 (0.80 2.48)
Blue collar 1.12 (0.86 1.46) 1.33 (0.75 2.36)
None/homemaker 1.11 (0.85 1.45) 1.21 (0.71 2.04)
Residential area
Capital area 1.00 1.00
Metropolitan area 1.40 (1.15 1.70) 1.52 (1.13 2.05)
Rural 1.39 (1.14 1.69) 1.50 (1.13 1.99)
High-risk drinking
No 1.00 1.00
Yes 0.96 (0.78 1.18) 1.25 (0.68 2.30)
Physical activity
Active 1.00 1.00
Inactive 0.80 (0.69 0.92) 1.06 (0.85 1.32)
Height (cm) 1.04 (1.03 1.06) 1.05 (1.03 1.07)
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smoking ≥ 20 years ago showed ORs of 1.30 (95% CI: 0.49–3.45) and 1.41 (95% CI: 1.05–1.90), respectively, for 
the obstructive spirometry pattern (comparison group: male never-smokers) (Fig. 2).
Among men, the relationship between smoking cessation status and obstructive spirometry pattern was 
generally similar across age groups, except in the 40–49 years age group. Men aged 40–49 years did not show any 
significant association between smoking cessation status and obstructive spirometry pattern (Table 3).
Discussion
In this cross-sectional study, we evaluated the association between smoking cessation status, considering the 
duration after smoking cessation, and obstructive spirometry pattern among Korean adults aged 40–79 years. 
Our findings suggested that a longer duration of smoking cessation was related to a decreasing tendency in the 
likelihood of having an obstructive spirometry pattern as well as an improvement of lung function parameters, 
among men. However, despite ≥ 20 years after smoking cessation, male ex-smokers still showed a higher likeli-
hood of having the obstructive spirometry pattern than male never-smokers. Analyses after stratification by age 
groups, which reduced the potential difference in age distribution across smoking cessation status categories, 
showed a tendency similar to that observed in the main analysis. In women, the number of ex-smokers with the 
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Figure 1.  Association between smoking cessation status and obstructive spirometry pattern according to the 
cumulative smoking exposure in men. Adjusted for age, educational level, household income, occupation, 
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Figure 2.  Association between smoking cessation status and obstructive spirometry pattern according to the 
age at smoking onset in men. Adjusted for cumulative smoking exposure, age, educational level, household 
income, occupation, residential area, physical activity, high-risk drinking, and height.
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Since our study was cross-sectional design, the partial restoration of lung function observed can be explained 
in two ways. First, although the rate of lung function decline normalized, the decrease in maximal lung function 
due to smoking was not fully restored. Second, acceleration of the age-related decline in lung function due to 
smoking could not be fully normalized even after long-term cessation. Our results are consistent with recent 
cohort study that although smoking cessation has a benefit in terms of lung function, lung injury from smoking 
could persist for decades after smoking  cessation18.
Tobacco smoking is related to pathophysiologic abnormalities of the lung, including  inflammation19–21, 
immune dysfunction and increased susceptibility to  infection22–24, mucus  hypersecretion25,26, genetic 
 abnormalities27,28, and airway  remodeling29–31. Although such lung abnormalities can improve with smoking 
cessation, there is evidence for sustained pathophysiological abnormalities in ex-smokers19,21. Lung injuries 
during the active smoking period, such as irreversible emphysematous change, may also contribute to persistent 
lung function impairment.
Findings regarding heavy smokers or adolescent-onset smokers are also notable. In male current-smokers, 
greater cumulative smoking exposure and adolescent-onset smoking showed relatively higher effect sizes (repre-
sented as ORs) for the obstructive spirometry pattern than their counterparts. However, among male ex-smokers 
with a smoking cessation duration of ≥ 20 years, participants showed similar effect sizes for the obstructive 
spirometry pattern across categories of cumulative smoking exposure and age at smoking onset. Therefore, 
long-term smoking cessation may be more beneficial for high-risk smokers than for low-risk smokers, in terms 
of recovering lung function. These findings reinforce prior research that heavy smokers benefited from smoking 
cessation more than did light smokers, in the first year after  cessation13.
This study has several limitations. First, the number of years of smoking cessation and cumulative smoking 
exposure were indirectly calculated without considering intermittent smoking history. Although self-reported 
smoking history is known to be highly reliable, the gap between the actual and estimated smoking history may 
have affected our results. Second, Korean women are likely to underreport their history of smoking owing to 
social unacceptance. Therefore, the number of female smokers was lower than expected in this study, and the 
results may have been distorted. Third, with the cross-sectional design, we could not estimate individuals’ age-
related decline in lung function. Instead, the likelihood of having an obstructive spirometry pattern was used 
to evaluate the lung function of participants. The possibility of unmeasured confounding due to factors such as 
passive smoking, occupational exposure to harmful particles, or individual variation in metabolic enzyme activity 
should also be  considered32,33. Thus, our results should be cautiously interpreted, when compared to the findings 
of similar studies. Further long-term prospective study, including accurate smoking history of women partici-
pants, is needed to evaluate impacts of smoking cessation on age-related decline in lung functions in Koreans.
Despite these limitations, this study has a major strength: this study was based on one of the most representa-
tive health statistics of the Korean population and a reliable measurement of lung function.
In conclusion, our study showed that a longer duration of smoking cessation was linked to a decreasing 
tendency in the likelihood of having an obstructive spirometry pattern among men. Our findings suggest that 
tobacco smoking causes long-lasting harm to lung function and indicates the importance of the prevention and 
cessation of smoking, particularly in high-risk male smokers.
Table 3.  Association between smoking cessation status and obstructive spirometry pattern according to age 
 groupa. OR odds ratio, CI confidence interval. a Adjusted for all covariates (cumulative smoking exposure, age, 
educational level, household income, occupation, residential area, physical activity, high-risk drinking, and 
height). b Obstructive spirometry pattern was defined as an  FEV1/FVC < 0.7.
Variables
Obstructive spirometry  patternb
Never-smoker
Ex-smoker (cessation years)
Current smoker ≥ 20 15–20 10–15 5–10  < 5
OR OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Age (years)
Men
 40–49 1.00 0.74 (0.18 3.01) 0.50 (0.11 2.32) 0.34 (0.08 1.40) 1.17 (0.42 3.26) 0.84 (0.32 2.22) 0.98 (0.45 2.12)
 50–59 1.00 1.75 (0.84 3.64) 1.08 (0.47 2.47) 1.69 (0.75 3.81) 2.16 (0.93 5.02) 2.02 (0.95 4.31) 3.29 (1.76 6.17)
 60–69 1.00 1.46 (0.92 2.33) 1.70 (1.02 2.83) 1.70 (0.94 3.05) 3.35 (1.89 5.93) 1.67 (0.91 3.05) 4.21 (2.62 6.77)
 70–79 1.00 1.64 (1.03 2.60) 1.15 (0.60 2.19) 1.83 (0.93 3.62) 4.34 (2.03 9.30) 3.37 (1.66 6.83) 4.07 (2.19 7.56)
Women
 40–49 1.00 3.12 (0.75 12.91) 4.73 (0.86 25.99) 3.33 (0.63 17.74) – – – – 2.13 (0.73 6.25)
 50–59 1.00 0.30 (0.04 2.30) – – 1.69 (0.18 15.81) – – 5.30 (1.11 25.38) 1.23 (0.46 3.33)
 60–69 1.00 – – – – 0.85 (0.16 4.38) – – 0.98 (0.22 4.35) 3.78 (1.47 9.73)
 70–79 1.00 1.08 (0.25 4.73) – – – – 6.90 (1.15 41.45) 0.89 (0.11 7.46) 5.11 (1.52 17.21)
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Methods
Ethical considerations. The study data were collected from the Korea National Health and Nutrition 
Examination Survey (KNHANES), which is conducted by the Korean government. The KNHANES data are 
anonymized and publicly available for research. Thus, this study was approved as an exemption by the Institu-
tional Review Board of Yonsei University’s Health System (IRB No: 4-2021-0663).
Study subjects and data sources. This was a cross-sectional study. The study data were collected during 
2015–2019 from the KNHANES VI, VII, and VIII. The KNHANES is a cross-sectional, nationally representative 
survey that assesses the health, risk factors for health, and nutritional status of Koreans; it is conducted annu-
ally by the Korea Centers for Disease Control and Prevention (KCDC). Details on the design and contents of 
the KNHANES are available on the KNHANES webpage (https:// knhan es. kdca. go. kr/ knhan es/ eng/ index. do).
The study included participants aged 40–79 years, which is the target population of the spirometry test in 
the KNHANES. Participants with asthma, with unreadable spirometry results, or who were unable to undergo 
the test were excluded from the study. Those who had incomplete or missing data were also excluded. The final 
study population included 6298 men and 8088 women.
Measures. The outcome variable was obstructive spirometry pattern, defined as an  FEV1/FVC < 0.734,35. 
Using pre-bronchodilator spirometry, lung function was measured at least two times for each participant and 
the largest value was reported.
Spirometry was performed by trained technicians, using the American Thoracic Society (ATS) /European 
Respiratory Society (ERS) 2005  standards36,37. The study included only valid spirometry results that met ATS/
ERS acceptability and repeatability criteria: (1) two or more spirometry curves should be free from artefacts, 
have good starts and show at least 6 s of exhalation; (2) two largest values of  FEV1 or FVC should be within 
150 mL of each  other36. The quality of the spirometry test was managed by the Korean Academy of Tuberculosis 
and Respiratory  Diseases38.
Participants were classified as never-smokers, ex-smokers, or current-smokers according to their self-reported 
smoking status. Ex-smokers were subdivided into five categories according to the duration after smoking cessa-
tion: < 5 years, 5–10 years, 10–15 years, 15–20 years, and ≥ 20 years.
The covariates were selected based on the previous literature. Pack-years of smoking (< 20  years, 
20–30 years, > 30 years), age (continuous variable), height (continuous variable)39, high-risk drinking (yes, 
no)40,41, physical activity (active, inactive)42, and socioeconomic factors such as education level (middle school 
or below, high school, college or above), household income (quartile of household income according to the 
2015–2019 KNHANES survey), occupation (white collar, pink collar, blue collar, none or homemaker), area of 
residence (capital, metropolitan, rural) were included as  covariates43,44. High-risk drinking was defined as hav-
ing more than seven (men) or five (women) drinks at one time, at least twice per  week45,46. Physical activity was 
evaluated using Global Physical Activity Questionnaire (GPAQ), developed by World Health  Organization47,48.
Statistical analyses. All analyses were performed separately by gender, considering gender-specific dif-
ferences in smoking rate and smoking effect on lung  function49,50. We compared the prevalence of obstructive 
spirometry pattern in current-smokers, in ex-smokers with various duration of cessation to that in never-smok-
ers.
Chi-square tests (for categorical variables) and one-way analysis of variance (for continuous variables) were 
performed to determine differences in general characteristics between participants according to their smoking 
cessation status. Multiple logistic regression analysis was performed to calculate ORs with 95% CIs for evaluating 
the relationship between smoking cessation status and obstructive spirometry pattern. Additionally, multiple 
linear regression analyses were conducted to identify whether smoking cessation status was related to  FEV1, 
FVC, or  FEV1/FVC.
The data analysis for this paper was generated using SAS software, Version 9.4 of the SAS System for Unix. 
Copyright © 2016 SAS Institute Inc. SAS and all other SAS Institute Inc. product or service names are registered 
trademarks or trademarks of SAS Institute Inc., Cary, NC, USA.
Data availability
The datasets generated during and/or analysed during the current study are available in the KNHANES webpage 
(Korean), [https:// knhan es. kdca. go. kr/ knhan es/ sub03/ sub03_ 02_ 05. do].
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